Allergic rhinitis: incidence and remission from childhood to young adulthood: a prospective studyVisa övriga samt affilieringar
2025 (Engelska)Ingår i: Pediatric Allergy and Immunology, ISSN 0905-6157, E-ISSN 1399-3038, Vol. 36, nr 4, artikel-id e70078Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Background: Longitudinal studies on allergic rhinitis (AR) incidence and remission from childhood to adulthood are limited. This study aimed to estimate AR incidence and remission from age 8 to 19 years and to identify related risk factors.
Methods: In 2006, all children in grades 1 and 2 (median age 8 years) in three municipalities in Northern Sweden were invited to participate in a questionnaire survey. The children in two of the municipalities underwent a skin prick test (SPT) for airborne allergens. The protocol was repeated at age 19 years. In total, 2250 participants (91% participation rate) completed the questionnaire, and 1338 underwent SPTs at 8 and 19 years of age.
Results: From age 8 to 19 years, the cumulative incidence of AR was 33.6%, significantly higher among girls than boys (37.4% vs. 29.8%, p <.001). Factors that independently increased the risk of developing AR were sensitisation by age 8 (adjusted odds ratio [aOR] 3.75, 95% confidence interval [CI] 2.68–5.23), sensitisation between 8 and 19 years (aOR 2.57, 95% CI 1.82–3.63), and female sex (aOR 1.71, 95% CI 1.30–2.26). The remission rate was 40.0%, with boys experiencing significantly higher remission than girls (45.4% vs. 32.2%, p =.015). The probability of remission was decreased by sensitisation before (aOR 0.26, 95% CI 0.13–0.53) and after age 8 years (aOR 0.20, 95% CI 0.05–0.77).
Conclusion: This study found a high incidence of AR between age 8 and 19 years, especially among girls, while boys had a higher remission rate. Sensitisation increased the risk of developing AR and decreased the remission rate.
Ort, förlag, år, upplaga, sidor
John Wiley & Sons, 2025. Vol. 36, nr 4, artikel-id e70078
Nyckelord [en]
allergic rhinitis, cohort study, incidence, questionnaire, remission, sensitisation
Nationell ämneskategori
Lungmedicin och allergi Pediatrik
Identifikatorer
URN: urn:nbn:se:umu:diva-238227DOI: 10.1111/pai.70078ISI: 001457311900001PubMedID: 40171962Scopus ID: 2-s2.0-105002069265OAI: oai:DiVA.org:umu-238227DiVA, id: diva2:1955366
Forskningsfinansiär
Hjärt-LungfondenAstma- och AllergiförbundetVetenskapsrådetVårdalstiftelsenVisare NorrRegion NorrbottenRegion VästerbottenUmeå universitetGöteborgs universitetVästra Götalandsregionen2025-04-302025-04-302025-04-30Bibliografiskt granskad